Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
3.830
-0.020 (-0.52%)
At close: Aug 21, 2026, 4:00 PM EDT
3.829
-0.002 (-0.04%)
After-hours: Aug 21, 2026, 6:33 PM EDT

Fulcrum Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
48.47197.5358.2125.5635.135.41
Short-Term Investments
270.37154.77182.81210.66167.82182.75
Cash & Short-Term Investments
318.84352.31241.02236.22202.92218.16
Cash Growth
48.91%46.17%2.03%16.41%-6.99%93.21%
Accounts Receivable
--2.10.540.233.64
Other Receivables
2.031.071.251.710.850.47
Receivables
2.031.073.342.251.084.11
Prepaid Expenses
1.084.15.563.733.523.73
Other Current Assets
0.9-----
Total Current Assets
322.85357.48249.92242.2207.52226
Property, Plant & Equipment
-7.079.5812.3915.977.37
Other Long-Term Assets
1.11.741.213.13.21.63
Total Assets
323.95366.28260.72257.69226.69235

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
3.431.591.162.763.644.79
Accrued Expenses
3.738.797.238.339.459.16
Current Portion of Leases
2.522.42.192.192.6-
Current Unearned Revenue
0.45---0.934.71
Other Current Liabilities
0.170.260.460.40.110.54
Total Current Liabilities
10.313.0511.0413.6816.7319.2
Long-Term Leases
2.764.046.448.6310.82-
Other Long-Term Liabilities
0.20.20.20.20.24.26
Total Liabilities
13.2617.2817.6822.527.7423.46

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.080.070.050.060.050.04
Additional Paid-In Capital
950.54943.04762.25744.94612.03514.36
Retained Earnings
-639.35-594.28-519.4-509.67-412.34-302.47
Comprehensive Income & Other
-0.570.170.13-0.14-0.8-0.4
Total Common Equity
310.7349243.03235.19198.94211.54
Shareholders' Equity
310.7349243.03235.19198.94211.54
Total Liabilities & Equity
323.95366.28260.72257.69226.69235

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
5.286.448.6310.8213.42-
Net Cash (Debt)
313.56345.86232.39225.4189.5218.16
Net Cash Growth
51.82%48.83%3.10%18.95%-13.14%93.24%
Net Cash Per Share
4.475.463.753.684.216.17
Filing Date Shares Outstanding
76.366.653.9861.9461.7640.63
Total Common Shares Outstanding
76.2966.5853.9761.9252.140.63
Working Capital
312.55344.43238.88228.52190.79206.8
Book Value Per Share
4.075.244.503.803.825.21
Tangible Book Value
310.7349243.03235.19198.94211.54
Tangible Book Value Per Share
4.075.244.503.803.825.21
Machinery
0.9911.1510.8410.6810.249.15
Construction In Progress
----0.03-
Leasehold Improvements
-7.127.127.17.16.29
SEC Filings: 10-K · 10-Q